These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10354174)

  • 1. Skin eruption as the presenting sign of Hunter syndrome IIB.
    Demitsu T; Kakurai M; Okubo Y; Shibayama C; Kikuchi Y; Mori Y; Sukegawa K; Mizuguchi M
    Clin Exp Dermatol; 1999 May; 24(3):179-82. PubMed ID: 10354174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of dermatan sulfate and heparan sulfate in the urine of a patient with the Hunter syndrome.
    Kimura A; Hayashi S; Tsurumi K
    Tohoku J Exp Med; 1980 Jul; 131(3):227-39. PubMed ID: 6447930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic "pebbling" skin eruption as a presenting sign of Hunter syndrome.
    Noh TK; Han JS; Won CH; Chang S; Choi JH; Moon KC; Lee MW; Yang JH; Soung JH
    Int J Dermatol; 2014 Dec; 53(12):e594-6. PubMed ID: 25267496
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucopolysaccharidoses type II: enzymatic activity and quantitative and qualitative studies of urinary glycosaminoglycans in five patients.
    Gallegos-Arreola MP; González-Noriega A; Zúñiga-González GM; Flores-Martínez SE; Morán Moguel MC; Figuera LE; Sánchez-Corona J
    Arch Med Res; 1997; 28(1):91-4. PubMed ID: 9078594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hunter syndrome follow-up after 1 year of enzyme-replacement therapy.
    Puiu M; Chirita-Emandi A; Dumitriu S; Arghirescu S
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23307460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mucopolysaccharidosis type II, Hunter's syndrome.
    Tylki-Szymańska A
    Pediatr Endocrinol Rev; 2014 Sep; 12 Suppl 1():107-13. PubMed ID: 25345092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iduronate sulfatase activity in serum, lymphocytes, and fibroblasts--simplified diagnosis of the Hunter syndrome.
    Liebaers I; Neufeld E
    Pediatr Res; 1976 Aug; 10(8):733-6. PubMed ID: 821034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved assay for iduronate 2-sulphate sulphatase in serum and its use in the detection of carriers of the Hunter syndrome.
    Archer IM; Harper PS; Wusteman FS
    Clin Chim Acta; 1981 Apr; 112(1):107-12. PubMed ID: 6786801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hunter syndrome with late age of presentation: clinical description of a case and review of the literature.
    Gupta A; Uttarilli A; Dalal A; Girisha KM
    BMJ Case Rep; 2015 May; 2015():. PubMed ID: 25976201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hunter syndrome: case report and review of literature.
    Ogunbiyi A; Adeyinka AO; Ogah SO; Baiyeroju AM
    West Afr J Med; 2006; 25(2):169-72. PubMed ID: 16918195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative structural studies of urinary glycosaminoglycans in the Hurler and Hunter syndromes.
    Ramage P; Cunningham WL
    Biochim Biophys Acta; 1975 Dec; 411(2):325-33. PubMed ID: 127616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hunter syndrome: prenatal diagnosis in maternal serum.
    Zlotogora J; Bach G
    Am J Hum Genet; 1986 Feb; 38(2):253-60. PubMed ID: 3080875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the nonreducing ends of heparan sulfates excreted by patients with mucopolysaccharidoses revealed by bacterial heparitinases: a new tool for structural studies and differential diagnosis of Sanfilippo's and Hunter's syndromes.
    Toma L; Dietrich CP; Nader HB
    Lab Invest; 1996 Dec; 75(6):771-81. PubMed ID: 8973472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prenatal diagnosis of Hunter syndrome using fetal plasma.
    Lissens W; Van Lierde M; Decaluwe J; Foulon W; Evrard P; Van Hoof F; Freund M; Liebaers I
    Prenat Diagn; 1988 Jan; 8(1):59-62. PubMed ID: 3125535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iduronate sulfatase determination for the diagnosis of the Hunter syndrome and the detection of the carrier state.
    Neufeld EF; Liebaers I; Lim TW
    Adv Exp Med Biol; 1976; 68():253-60. PubMed ID: 820168
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiple sulphatase deficiency with early onset.
    Vamos E; Liebaers I; Bousard N; Libert J; Perlmutter N
    J Inherit Metab Dis; 1981; 4(2):103-4. PubMed ID: 6115093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hunter syndrome: resolution of extensive typical skin lesions after 9 months of enzyme replacement therapy with idursulfase.
    Marín LL; Gutiérrez-Solana LG; Fernández AT
    Pediatr Dermatol; 2012; 29(3):369-70. PubMed ID: 21995841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical phenotype of two patients with a complete deletion of the iduronate-2-sulphatase gene (mucopolysaccharidosis II--Hunter syndrome).
    Wraith JE; Cooper A; Thornley M; Wilson PJ; Nelson PV; Morris CP; Hopwood JJ
    Hum Genet; 1991 Jun; 87(2):205-6. PubMed ID: 1906048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hunter disease (mucopolysaccharidosis type II) in a karyotypically normal girl.
    Clarke JT; Willard HF; Teshima I; Chang PL; Skomorowski MA
    Clin Genet; 1990 May; 37(5):355-62. PubMed ID: 2112988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.